WARF Therapeutics


Jump to section:

WARF Therapeutics Drug Discovery Seminar Series

WARF Therapeutics is proud to partner with several departments to offer seminar series events to bring in national experts who will share their translational drug discovery experience with campus.

If you are interested in drug discovery, please join us at any of these events.


*** POSTPONED - We will share the updated date as soon as we have it. ***
Craig Erickson, MD, Cincinnati Children’s Hospital. Dr. Erickson’s group carries out preclinical and clinical research to develop new targeted drug treatments in developmental disabilities (autism spectrum disorders, Fragile X syndrome, and Angelman syndrome). He is a leading expert in conducting clinical trials in individuals with Fragile X. 

*** POSTPONED - We will share the updated date as soon as we have it. ***
Featured Speaker Goutham Narla, MD, Ph.D.

Seminar Title: Drugging the undruggable: lessons from DNA tumor viruses, cancer mutations, and small molecules
Dr. Narla earned his BS in Biology and Economics from Santa Clara University in California and his MD, PhD, and performed his residency at Mount Sinai School of Medicine in New York. He moved to Ohio in 2012 to work at Case Western Reserve University (CWRU) and in July 2018, he joined the faculty at Michigan Medicine to become the seventh Chief of the Division of Genetic Medicine.

*** POSTPONED - We will share the updated date as soon as we have it. ***
Featured Speaker Robert Yarchoan, MD

Seminar Title: The Spectrum of KSHV-associated Diseases: Pathogenesis and Insights for Therapy
Dr. Robert Yarchoan received his B.A. from Amherst College and his M.D. from the University of Pennsylvania. He joined the laboratory of Dr. Samuel Broder, where he played a major role in the development of the first effective therapies for HIV infection, including zidovudine (AZT), didanosine (ddI), and zalcitabine (ddC). His current research interests are focused on AIDS-related malignancies, especially tumors caused by Kaposi's sarcoma-associated herpesvirus (KSHV).

Featured Speaker Ben Cravatt, The Scripps Research Institute

Dr. Cravatt earned his BS in Biological Sciences and a BA in History from Stanford University and his PhD from Scripps Research Institute. He is a professor in the Department of Chemistry at Scripps Research Institute in Sand Diego.